Fiercest Women in Life Sciences: Nominate for 2025
Nominations are now open for the Fiercest Women in Life Sciences 2025 awards. Help us recognize the most innovative and inspiring leaders in biopharma and medtech.
biotechnology
Read More
1st Biotech IPO Since February: LB Pharma Upsizes Deal
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
CEO Post: Pfizer Vet Leads 1 New Phase 3 Biotech Firm
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
Pfizer vet to lead 1 new phase 3-ready biotech as CEO
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.
IL-17 Drug Phase 3 Success for Junshi’s Psoriasis Med
Junshi Biosciences reports a major phase 3 win for its new il-17 drug targeting psoriasis, signaling a significant advancement and a planned push into the China market.
Gout Drug from Atom Shows Phase 3 Win Over Rivals
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.